Cargando…
MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer
BACKGROUND: The morbidity and mortality of colorectal cancer (CRC) remain high, posing a serious threat to human life and health. The early diagnosis and prognostic evaluation of CRC are two major challenges in clinical practice. MTUS1 is considered a tumour suppressor and can play an important role...
Autores principales: | Cheng, Lin-Yao, Huang, Mao-sen, Zhong, Hua-Ge, Ru, Hai-Ming, Mo, Si-Si, Wei, Chun-Yin, Su, Zi-Jie, Mo, Xian-Wei, Yan, Lin-Hai, Tang, Wei-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375397/ https://www.ncbi.nlm.nih.gov/pubmed/35962436 http://dx.doi.org/10.1186/s12957-022-02702-2 |
Ejemplares similares
-
Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer
por: Huang, Mao-Sen, et al.
Publicado: (2022) -
Anlotinib suppresses metastasis and multidrug resistance via dual blockade of MET/ABCB1 in colorectal carcinoma cells
por: Yan, Lin-Hai, et al.
Publicado: (2021) -
Low MTUS1 Protein Expression Is Associated with Poor Survival in Patients with Colorectal Adenocarcinoma
por: Park, Hosub, et al.
Publicado: (2023) -
Upregulated Linc01836 in Serum Promisingly Serving as a Diagnostic and Prognostic Biomarker for Colorectal Cancer
por: Shen, Lei, et al.
Publicado: (2022) -
Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
por: Li, Chen, et al.
Publicado: (2016)